Log in or Sign up for Free to view tailored content for your specialty!
Gynecologic Cancer News
Cervical dysplasia incidence decreased over 14 years for women younger than 25 years
From 2007 to 2020, the incidence of cervical intraepithelial neoplasia grades 1, 2 and 3 continuously decreased among women aged 15 to 25 years while increasing among women aged 25 to 29 years, researchers reported.
VIDEO: Significant need for better patient education in endometrial cancer
Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about better patient education in endometrial cancer patients.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Racial disparities in access to care, diagnostic delay in endometrial cancer
Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about racial disparities in endometrial cancer.
VIDEO: Addressing obesity in endometrial cancer patients who want to have children
Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about obesity in endometrial cancer patients.
VIDEO: Precision medicine, diagnosis management, other advancements in endometrial cancer
Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about recent advancements in endometrial cancer care.
AI-driven app shows ‘benefits across the board’ for managing cancer symptoms through diet
CHICAGO — Most individuals with cancer who used an AI-based nutritional platform reported the application helped them regulate their diets and improved their quality of life, according to study results presented at ASCO Annual Meeting.
Racial, ethnic minorities have similar outcomes in phase 1 trials for advanced cancers
Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.
Scaling Mount Kilimanjaro gives oncologist lesson in teamwork, personal fulfillment
When Ami P. Vaidya, MD, spent a week hiking to the top of Mount Kilimanjaro, everyone in her group hit a “low point” at various times in terms of energy and determination.
GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes
People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.
Tisotumab vedotin shows superior survival results in advanced cervical cancer
Tisotumab vedotin for recurrent cervical cancer resulted in significantly longer survival outcomes compared with chemotherapy alone, according to results from a phase 3 randomized study published in The New England Journal of Medicine.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read